Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions

Study Overview
=================
Brief Summary
-----------------
Design: The proposed study is a randomized study comparing the relative effectiveness of three lesion modification strategies (RA, SBS, or OAS) in the treatment of obstructive CCLs using the change in lumen size measurements (MLA, RLA, MSA and the ratio of MSA/MLA) obtained with IVUS or OCT. Patients will be blinded to treatment assignment for the duration of the study. Treatment: Patients who are randomized to RA will undergo coronary wiring of the CCL and subsequent advancement of the RA burr. The RA system is performed using standard technique under intravenous infusion of heparin. The atherectomy burr size will be determined by the operator. Patients who are randomized to OAS will undergo coronary wiring of the CCL and subsequent advancement of the OAS according to the manufacturer's guidelines. Control: Patients who are randomized to SBS will undergo coronary wiring and balloon inflation with SBS performed by standard technique under intravenous infusion of heparin. SBS will be used according to the AngioSculpt manufacturer's guidelines. Duration: 30 days follow-up. The primary trial objective is to determine which of the three treatment strategies for treating calcified coronary lesions (RA, SBS, or OA) is superior for obtaining higher ratio of final in-stent minimum lumen area/reference lumen area, as determined by IVUS or OCT (primary study endpoint). The secondary objectives are to compare the following: Difference in pre- vs. post-treatment minimum lumen area (MLA, lumen area gain), as determined by IVUS or OCT (secondary endpoint) Mean final minimal stent area (MSA), as assessed by IVUS or OCT (secondary endpoint) Ratio of final in-stent minimum lumen diameter/reference lumen diameter, as determined by quantitative coronary angiography (secondary endpoint) Incidence of major adverse cardiac events (death, myocardial infarction, target vessel revascularization) during 30 days of follow-up (secondary endpoints) Procedure time, fluoroscopy time, and contrast volume (secondary endpoints)

Official Title
-----------------
A Single Center, Randomized Trial of Treatment Strategies for Obstructive Calcified Coronary Lesions: Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions (ECSPAND)

Conditions
-----------------
Atherosclerosis, Coronary Artery Disease

Intervention / Treatment
-----------------
* Device: Rotational atherectomy
* Device: Orbital atherectomy
* Device: Scoring balloon system


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years of age or older Clinical indication for coronary intervention such as ischemic symptoms and/or a positive functional study Found to have a de novo severe calcification (radio opacities noted without cardiac motion on contrast injection, lesion length >15 mm, or presence of >270° calcification on one cross-sectional view of IVUS) in a native coronary artery on fluoroscopy or IVUS Exclusion Criteria: Subject is currently participating in an investigational device or pharmaceutical treatment protocol Persistent (>10 minutes) hypotension (systolic blood pressure <90 mmHg) Need for revascularization of multiple lesions during the index PCI Unprotected left main (>50%) or equivalent left main disease Non-calcified lesions Chronic total occlusions, extreme lesion tortuosity including Type B/C lesions Severe left ventricular dysfunction (ejection fraction <25%) History of bleeding diathesis or coagulopathy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Rotational atherectomy<br>RA protocol: After IVUS protocol, patients who are randomized to RA will undergo coronary wiring of the target lesion and subsequent advancement of the RA burr. The RA system is performed using standard technique under intravenous infusion of heparin. The atherectomy burr size will be determined by the operator. | Device: Rotational atherectomy<br>* Pre-stenting lesion modification using the rotational atherectomy device using standard technique under intravenous infusion of heparin. Burr size will be selected by the operator according to vessel size. IVUS images will be obtained before lesion modification and after stenting.<br>|
| Active Comparator: Orbital atherectomy<br>OAS protocol: After IVUS protocol, patients who are randomized to OAS will undergo coronary wiring of the target lesion and subsequent advancement of the OAS according to the manufacturer's guidelines. | Device: Orbital atherectomy<br>* Pre-stenting lesion modification using the orbital atherectomy device according the manufacturer's guidelines. IVUS images will be obtained before lesion modification and after stenting.<br>|
| Active Comparator: Scoring balloon system<br>SBS protocol: After IVUS protocol, patients who are randomized to SBS will undergo coronary wiring of the target lesion and balloon inflation with SBS performed by standard technique under intravenous infusion of heparin. SBS will be used according to the manufacturer's guidelines. | Device: Scoring balloon system<br>* Pre-stenting lesion modification using the scoring balloon system according the manufacturer's guidelines. IVUS images will be obtained before lesion modification and after stenting.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Ratio of final in-stent minimum lumen area/reference lumen area | IVUS measurement based determination of ratio of final in-stent minimum lumen area/reference lumen area, as determined by IVUS | Immediately after stenting | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Difference in pre- vs. post-treatment minimum lumen area (MLA, lumen area gain) | IVUS measurement based determination of difference in pre- vs. post-treatment minimum lumen area (MLA, lumen area gain) | Immediately after stenting | 
| Mean final minimal stent area (MSA) | IVUS measurement based determination of Mean final minimal stent area (MSA) | Immediately after stenting | 
| Ratio of final in-stent minimum lumen diameter/reference lumen diameter | Quantitative coronary angiography based determination of ratio of final in-stent minimum lumen diameter/reference lumen diameter | Immediately after stenting | 
| Lower incidence of major adverse cardiac events (death, myocardial infarction, target vessel revascularization) during 30 days of follow-up |  | 30 days | 
| Procedure time |  | Immediately after the end of the interventional procedure | 
| Fluoroscopy time |  | Immediately after the end of the interventional procedure | 
| Contrast volume |  | Immediately after the end of the interventional procedure | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Coronary Atherectomy, percutaneous coronary intervention